Anti-pd-l1 Nanobody And Use Thereof

  • Published: Jun 20, 2019
  • Earliest Priority: Aug 04 2016
  • Family: 12
  • Cited Works: 3
  • Cited by: 0
  • Cites: 2
  • Additional Info: Cited Works Full text
Abstract

Disclosed is a nanobody against the human programmed death factor PD-L1. The antibody has the function of blocking the binding of PD-L1 to the receptor PD-1. Disclosed are the nanobody and the gene sequence encoding the nanobody, the corresponding expression vector and the host cell capable of expressing the nanobody, and the method for producing the nanobody. At the same time, also disclosed is the sequence of the humanized PD-L1 nanobody. The humanized nanobody still has the function of blocking the binding of PD-L1 to PD-1, and has a relatively high affinity and a relatively good specificity.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jun 20, 2019
  • Application: Aug 3, 2017
    AU AU 2017/305366 A
  • Priority: Aug 3, 2017
    CN CN 2017095884 W
  • Priority: Aug 4, 2016
    CN CN 201610634596 A

Download Citation


Sign in to the Lens

Feedback